Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

86,510 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Grenz Ray Therapy for Skin DisordersPayerPolicy · BCBSMS-L-8-01-402-A51E8CD030	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	GLP-1 AgonistPayerPolicy · BCBSMS-L-5-01-428-FAB47CA451	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Givlaari (givosiran)PayerPolicy · BCBSMS-L-5-01-553-EF6BCF8E82	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Giant Cell ArteritisPayerPolicy · BCBSMS-L-5-01-516-9B96272435	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes (ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, and TP53)PayerPolicy · BCBSMS-A-2-04-148-8115C66CD9	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline Genetic Testing for Hereditary Diffuse Gastric Cancer (CDH1, CTNNA1)PayerPolicy · BCBSMS-A-2-04-154-8867A4F801	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2)PayerPolicy · BCBSMS-A-2-04-02-F876CA23A6	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline Genetic Testing for Gene Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1)PayerPolicy · BCBSMS-A-2-04-126-72580C67FF	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline Genetic Testing for Familial Cutaneous Malignant Melanoma (CDKN2A, CDK4)PayerPolicy · BCBSMS-A-2-04-44-8277CF25B1	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Prostate Cancer (BRCA1/2, Homologous Recombination Repair Gene Alterations, NTRK Gene Fusion)PayerPolicy · BCBSMS-A-2-04-155-9F10F55CE9	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Ovarian Cancer (BRCA1, BRCA2, Homologous Recombination Deficiency, NTRK)PayerPolicy · BCBSMS-A-2-04-156-0885A81941	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Breast Cancer (BRCA1, BRCA2, PIK3CA, Ki-67, RET, BRAF, ESR1, NTRK)PayerPolicy · BCBSMS-A-2-04-151-7760F8E956	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	GepantsPayerPolicy · BCBSMS-L-5-01-566-B56EA612BE	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genotyping for 9p21 Single Nucleotide Polymorphisms to Predict Risk of Cardiovascular Disease or AneurysmPayerPolicy · BCBSMS-L-2-04-430-B2C8E7C417	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genotype-Guided Warfarin DosingPayerPolicy · BCBSMS-A-2-04-48-C9C95A4EB3	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genotype-Guided Tamoxifen TreatmentPayerPolicy · BCBSMS-L-2-04-464-AE27962C69	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Rett SyndromePayerPolicy · BCBSMS-L-2-04-461-9704F2E713	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for PTEN Hamartoma Tumor SyndromePayerPolicy · BCBSMS-A-2-04-88-8E634EBE0B	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Predisposition to Inherited Hypertrophic CardiomyopathyPayerPolicy · BCBSMS-A-2-02-28-B52C5ADA50	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for NeurofibromatosisPayerPolicy · BCBSMS-A-2-04-137-38F0E1BD5A	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Mitochondrial DisordersPayerPolicy · BCBSMS-A-2-04-117-3AC46F4D35	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Macular DegenerationPayerPolicy · BCBSMS-A-2-04-103-BA399B4F78	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer SyndromesPayerPolicy · BCBSMS-A-2-04-08-E4EA31341C	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin TreatmentPayerPolicy · BCBSMS-L-2-04-454-1599E6808B	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Limb-Girdle Muscular DystrophiesPayerPolicy · BCBSMS-L-2-04-459-3D07660091	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Li-Fraumeni SyndromePayerPolicy · BCBSMS-A-2-04-101-1DB817BC83	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Lactase InsufficiencyPayerPolicy · BCBSMS-L-2-04-462-E31AD7BC88	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Inherited ThrombophiliaPayerPolicy · BCBSMS-A-2-04-82-6C7B6F904A	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Idiopathic Dilated CardiomyopathyPayerPolicy · BCBSMS-A-2-04-114-42CA864FE8	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Hereditary HemochromatosisPayerPolicy · BCBSMS-L-2-04-460-C76F8D1F8C	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Helicobacter Pylori TreatmentPayerPolicy · BCBSMS-L-2-04-428-29DC3DD6CE	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for FMR1 Variants (including Fragile X Syndrome)PayerPolicy · BCBSMS-A-2-04-83-7E72F2FC1F	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for FLT3, NPM1, CEBPA, IDH1, and IDH2 Variants in Cytogenetically Normal Acute Myeloid LeukemiaPayerPolicy · BCBSMS-A-2-04-124-FCD6A93F62	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for EpilepsyPayerPolicy · BCBSMS-A-2-04-109-56323236E8	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Duchenne and Becker Muscular DystrophyPayerPolicy · BCBSMS-A-2-04-86-DDEBB6164A	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Diagnosis and Management of Mental Health ConditionsPayerPolicy · BCBSMS-A-2-04-110-FD85B66194	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital AnomaliesPayerPolicy · BCBSMS-A-2-04-59-060ADA6874	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Cardiac Ion ChannelopathiesPayerPolicy · BCBSMS-A-2-04-43-EAA58A075A	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Alzheimer DiseasePayerPolicy · BCBSMS-A-2-04-13-2BE1CE18AE	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Testing for Alpha-1 Antitrypsin DeficiencyPayerPolicy · BCBSMS-A-2-04-79-A5B174E646	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic TestingPayerPolicy · BCBSMS-L-2-04-409-2AC4FA8B87	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic Cancer Susceptibility Panels Using Next Generation SequencingPayerPolicy · BCBSMS-A-2-04-93-E900B52BB3	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerPayerPolicy · BCBSMS-A-2-04-33-F7F41DEA46	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	General Health PanelPayerPolicy · BCBSMS-L-2-04-408-911DB9ED6A	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	General Approach to Genetic TestingPayerPolicy · BCBSMS-A-2-04-91-F355C7BDA1	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Gene Therapy for Treatment of Sickle Cell DiseasePayerPolicy · BCBSMS-L-5-01-607-B3C0B1DEB7	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Gene Therapy for the Treatment of Metachromatic LeukodystrophyPayerPolicy · BCBSMS-L-5-01-611-D4CDEC3EA7	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Gene Therapy for the Treatment of Hemophilia BPayerPolicy · BCBSMS-L-5-01-594-E1844F95BA	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Gene Therapy for Inherited Retinal DystrophyPayerPolicy · BCBSMS-A-2-04-144-E23C8A8D64	New policy
Aug 2, 2026	Blue Cross & Blue Shield of Mississippi	Gene Expression Testing in the Evaluation of Patients with Stable Ischemic Heart DiseasePayerPolicy · BCBSMS-L-2-04-453-300AF026F8	New policy